Live liver donors: Are they at a higher risk for post-operative thrombotic complications?

Live liver donor transplantation to adult recipients is becoming a common practice, increasing the organ pool and providing an alternative to whole cadaveric liver transplantation. These patients are healthy adults without serious medical conditions and typically have normal coagulation profiles preoperatively. Right hepatic lobectomy is usually performed for adult recipients, while left hepatic lobectomy is performed for pediatric recipients. Removal of the whole right lobe from the donors may expose theses patients to multiple intraoperative and postoperative complications. Hypercoagulability has been identified as a serious complication which leads to thromboembolic phenomena with potential fatal consequences. The primary aim of this review is to look at possible changes in post-operative coagulation dynamics that may increase the risk for development of thromboembolic complications in live liver donors. In this article, we stress the importance of addressing the issue that conventional clotting tests (PT, INR, PTT) are unable to detect a hypercoagulable state, and therefore, we should examining alternative laboratory tests to improve diagnosis and early detection of thrombotic complications. Measurement of natural anticoagulant/procoagulant biomarkers combined with conventional coagulation studies and thromboelastography offers a more accurate assessment of coagulation disorders. This allows earlier diagnosis, permitting appropriate intervention sooner, hence avoiding potential morbidity and mortality. Biomarkers that may be evaluated include, but are not limited to: protein C, soluble P-selectin, antithrombin III, thrombin-antithrombin complex, and thrombin generation complex.

[1]  T. Kanematsu,et al.  Is preservation of middle hepatic vein tributaries during right hemi-hepatectomy beneficial for live donor liver transplantation? , 2012, Hepato-gastroenterology.

[2]  T. Wen,et al.  Safety of patients with a graft to body weight ratio less than 0.8% in living donor liver transplantation using right hepatic lobe without middle hepatic vein. , 2012, Hepato-gastroenterology.

[3]  V. Kak.  Mediators of systemic inflammatory response syndrome and the role of recombinant activated protein C in sepsis syndrome. , 2011, Infectious disease clinics of North America.

[4]  Y. Maehara,et al.  Minimal Hilar Dissection Prevents Biliary Anastomotic Stricture After Living Donor Liver Transplantation , 2011, Transplantation.

[5]  Panagiota Anyfanti,et al.  Immunomodulatory therapy for sepsis: an update , 2011, Expert review of anti-infective therapy.

[6]  H. Baba,et al.  Long-Term Follow-Up After Right Hepatectomy for Adult Living Donation and Attitudes Toward the Procedure , 2011, Annals of surgery.

[7]  T. Wen,et al.  Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[8]  E. Tapper,et al.  Evaluation of Hemostatic Factors in Patients Undergoing Major Hepatic Resection and Other Major Abdominal Surgeries , 2011, The American surgeon.

[9]  A. Tuzuner,et al.  Living-donor hepatectomy. , 2011, Transplantation proceedings.

[10]  Y. Takeda,et al.  Donor Hepatectomy for Living Donor Liver Transplantation: Learning Steps and Surgical Outcome , 2011, Digestive Diseases and Sciences.

[11]  M. Dayangaç,et al.  Analysis of right lobe living-liver donor complications: a single center experience. , 2011, Experimental and Clinical Transplantation.

[12]  Rodrigo Siqueira-Batista,et al.  Sepsis: an update. , 2011, Revista Brasileira de terapia intensiva.

[13]  A. Rezaie.  Regulation of the protein C anticoagulant and antiinflammatory pathways. , 2010, Current medicinal chemistry.

[14]  A. Gothot,et al.  La Thrombinographie : vers une globalisation des tests de la coagulation. , 2009 .

[15]  P. White,et al.  Does Thromboelastography Predict Postoperative Thromboembolic Events? A Systematic Review of the Literature , 2009, Anesthesia and analgesia.

[16]  F. Guadagni,et al.  Soluble P-selectin as a marker of in vivo platelet activation. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[17]  T. van der Poll,et al.  Recombinant human activated protein C: current insights into its mechanism of action , 2007, Critical care.

[18]  J. Belghiti,et al.  Hypercoagulability after partial liver resection , 2007, Thrombosis and Haemostasis.

[19]  M. Abouljoud,et al.  Hypercoagulability risks among adult living liver donors. , 2006, Transplantation proceedings.

[20]  S. Mallett,et al.  Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. , 2006, Journal of cardiothoracic and vascular anesthesia.

[21]  J. Leitner,et al.  Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia , 2006, Clinical pharmacology and therapeutics.

[22]  D. Wagner,et al.  New links between inflammation and thrombosis. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Differding,et al.  Hypercoagulability is most prevalent early after injury and in female patients. , 2005, The Journal of trauma.

[24]  J. Emond,et al.  One‐year morbidity after donor right hepatectomy , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  M. Rizzetto,et al.  Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  R. Sandler,et al.  Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: A systematic review , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  C. Esmon,et al.  The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. , 2000, Blood.

[28]  A. Marcos.  Right lobe living donor liver transplantation: A review , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[29]  G. Lip,et al.  Soluble P-selectin in Atherosclerosis: A Comparison with Endothelial Cell and Platelet Markers , 1997, Thrombosis and Haemostasis.

[30]  J. Crespo,et al.  Value of plasma P-selectin for vascular complications in liver transplantation. , 1996, Clinical transplantation.

[31]  Robert C. Wolpert,et al.  A Review of the , 1985 .